P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Jonathan de Wilde(Utrecht University), Minke A.E. Rab(Utrecht University), Brigitte van Oirschot(Utrecht University), Titine Ruiter(Utrecht University), Wouter W. van Solinge(Utrecht University), Richard van Wijk(Utrecht University), Judith Jans(University Medical Center Utrecht), Lenny Dang(Millennium Engineering and Integration (United States)), Megan Wind‐Rotolo(Bristol-Myers Squibb (United States)), Anna van Rhenen(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Cited by 2
Related Papers
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
|Nature Medicine|2020|1k
Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma
|Cancer Cell|2007|949
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> Mutations
|Cancer Discovery|2017|457